✦ LIBER ✦

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study

✍ Scribed by R. Greil; M. Moik; R. Reitsamer; S. Ressler; M. Stoll; K. Namberger; C. Menzel; B. Mlineritsch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of bevacizumab in combi

✍ Zhao, Meng; Pan, Xueliang; Layman, Rachel; Lustberg, Maryam B.; Mrozek, Ewa; Mac 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 403 KB

Neoadjuvant rh-endostatin, docetaxel and

✍ Jianghao Chen, Qing Yao, Dong Li, Juliang Zhang, Ting Wang, Ming Yu… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 175 KB

All-oral vinorelbine (NVBo) and capecita

✍ N. Tubiana-Mathieu; P. Bougnoux; D. Becquart; A. Chan; F. Majois; M. Espie; R. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

First-line trastuzumab (H), oral vinorel

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; L. Goedhals; M. Gil G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

5054 Safety and efficacy of the combinat

✍ V. Michalaki; S. Gennatas; C. Gennatas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Metronomic oral combination chemotherapy

✍ Masataka Yoshimoto, Shintaro Takao, Masaru Hirata… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 245 KB